OBJECTIVES:   Upon completion of this activity, the participant should be able to:
1. Describe the advantages and disadvantages of SAVR vs. TAVR and a first valve replacement. 
2. Identify the most appropriate antiplatelet or anticoagulant therapy for a patient who has a bioprosthetic aortic valve. 
3. Describe what the BSWH TAVR Collaborative is and explain its objectives. 

FACULTY DISCLOSURE: Robert C. Stoler, MD is on the Advisory Board and a Proctor for Medtronic, Boston Scientific and Edwards Lifesciences Inc. 

PLANNERS DISCLOSURE: Ramachandra Reddy, MD and Robert Widmer, MD have no relevant financial relationship(s) to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

All relevant financial relationships have been mitigated.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For information, please contact [email protected]